Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2012
Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cellsNourredine Himoudi, Daniel A Morgenstern, Mengyong Yan, et al.Haematologica|March 31, 2022
Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myelomaOrtal Harush, Nathalie Asherie, Shlomit Kfir-Erenfeld, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 6, 2005
High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporationYangbing Zhao, Zhili Zheng, Cyrille J Cohen, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 6, 2016
Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase SystemDrew C Deniger, Anna Pasetto, Eric Tran, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytesLaura A Johnson, Bianca Heemskerk, Daniel J Powell, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|August 28, 2022
Multifunctional nanoprobe for real-time in vivo monitoring of T cell activationOshra Betzer, Yue Gao, Astar Shamul, et al.Cancer Research|March 17, 2007
Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signalingYangbing Zhao, Maria R Parkhurst, Zhili Zheng, et al.Human Gene Therapy|March 7, 2009
Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytesStephanie Jones, Peter D Peng, Shicheng Yang, et al.Cancer Immunology, Immunotherapy : CII|July 15, 2010
Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansionStephanie L Goff, Laura A Johnson, Mary A Black, et al.Cancer Immunology, Immunotherapy : CII|March 24, 2012
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapySivan Sapoznik, Rona Ortenberg, Gilli Galore-Haskel, et al.Pageof 6